Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy

Edward V. Maytin; Sanjay Anand; Nobuyuki Sato; Brian Moore; Judith Mack; Christopher Gasbarre; Samantha Keevey; Bernhard Ortel; Alok Sinha; Amor Khachemoune

doi:10.1117/12.646880

6 March 2006 Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy

Edward V. Maytin, Sanjay Anand, Nobuyuki Sato, Brian Moore, Judith Mack, Christopher Gasbarre, Samantha Keevey, Bernhard Ortel, Alok Sinha, Amor Khachemoune

Author Affiliations +

Proceedings Volume 6139, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XV; 613909 (2006) https://doi.org/10.1117/12.646880
Event: SPIE BiOS, 2006, San Jose, California, United States

Abstract

Photodynamic therapy (PDT) using aminolevulinic acid (ALA) relies upon the uptake of ALA into cancer cells, where it is converted into a porphyrin intermediate, protoporphyrin IX (PpIX) that is highly photosensitizing. For large or resistant tumors, however, ALA/PDT is often not completely effective due to inadequate PpIX levels. Therefore, new approaches to enhance the intracellular production of PpIX are sought. Here, we describe a general approach to improve intracellular PpIX accumulation via manipulations that increase the expression of an enzyme, coproporphyrinogen oxidase (CPO), that is rate-determining for PpIX production. We show that nuclear hormones that promote terminal differentiation, e.g. vitamin D or androgens, can also increase the accumulation of PpIX and the amount of killing of the target cells upon exposure to light. These hormones bind to intracellular hormone receptors that translocate to the nucleus, where they act as transcription factors to increase the expression of target genes. We have found that several other transcription factors associated with terminal differentiation, including members of the CCAAT enhancer binding (C/EBP) family, and a homeobox protein named Hoxb13, are also capable of enhancing PpIX accumulation. These latter transcription factors appear to interact directly with the CPO gene promoter, resulting in enhanced CPO transcriptional activity. Our data in several different cell systems, including epithelial cells of the skin and prostate cancer cells, indicate that enhancement of CPO expression and PpIX accumulation represents a viable new approach toward improving the efficacy of ALA/PDT.

Citation Download Citation

Edward V. Maytin, Sanjay Anand, Nobuyuki Sato, Brian Moore, Judith Mack, Christopher Gasbarre, Samantha Keevey, Bernhard Ortel, Alok Sinha, and Amor Khachemoune "Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy", Proc. SPIE 6139, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XV, 613909 (6 March 2006); https://doi.org/10.1117/12.646880

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available